(NASDAQ: ACET) Adicet Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Adicet Bio's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast ACET's revenue for 2025 to be $1,653,715,000, with the lowest ACET revenue forecast at $1,653,715,000, and the highest ACET revenue forecast at $1,653,715,000. On average, 1 Wall Street analysts forecast ACET's revenue for 2026 to be $1,653,715,000, with the lowest ACET revenue forecast at $1,653,715,000, and the highest ACET revenue forecast at $1,653,715,000.
In 2027, ACET is forecast to generate $2,621,138,275 in revenue, with the lowest revenue forecast at $2,621,138,275 and the highest revenue forecast at $2,621,138,275.